Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SLC13A5-IN-1 is a selective inhibitor of sodium-citrate co-transporter (SLC13A5),completely blocks the uptake of 14C-citrate(IC50 : 0.022 μM in HepG2 cells).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 43.00 | |
5 mg | In stock | $ 98.00 | |
10 mg | In stock | $ 163.00 | |
25 mg | In stock | $ 297.00 | |
50 mg | In stock | $ 497.00 | |
100 mg | In stock | $ 693.00 | |
200 mg | In stock | $ 982.00 | |
500 mg | In stock | $ 1,450.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 123.00 |
Description | SLC13A5-IN-1 is a selective inhibitor of sodium-citrate co-transporter (SLC13A5),completely blocks the uptake of 14C-citrate(IC50 : 0.022 μM in HepG2 cells). |
Targets&IC50 | HepG2/14C-Citrate uptake:0.022 μM , Recombinant hSLC3A5/14C-Citrate Uptake:0.056 μM |
In vitro | In HepG2/14C-Citrate Uptake Assay,SLC13A5-IN-1 exhibits an IC50 of 0.022 μM . HepG2 cells endogenously express hSLC13A5 transporter which is responsible for the uptake of citrate into these cells. Uptake of 14C-citrate can be completely blocked by SLC13A5-IN-1 and the signal can be competed with unlabelled citrate.In recombinant hSLC3A5/14C-Citrate Uptake Assay, SLC13A5-IN-1 exhibits an IC50 of 0.056 μM . SLC13A5-IN-1 exhibits an IC50 of 100 μM in recombinant Human GlyT2/3H-Glycine Uptake Assay. The human embryonic kidney 293 cells are used that stably over-express the human GlyT2 receptor which is responsible for the uptake of glycine into these cells. Uptake of 3H-glycine can be completely blocked by SLC13A5-IN-1. |
Molecular Weight | 461.79 |
Formula | C19H19Cl3N2O3S |
CAS No. | 2227548-95-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5 mg/ml (10.83 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SLC13A5-IN-1 2227548-95-8 Metabolism Stearoyl-CoA Desaturase (SCD) hSLC3A5 metabolic SLC-13A5-IN-1 SLC13A5IN1 Inhibitor Citrate SLC13A5 cardiovascular inhibit disease Sodium Channel Uptake Na channels Na+ channels SLC13A5 IN 1 inhibitor